Promising cancer therapy advanced by chemical explanation
12/15/2015
Radiation therapy: A chilling word that creates images of burn-injuries where the cancer killing ray went through the skin.
People with darker skin types more likely to have pigment "spots" on palms and soles
12/15/2015
People with darker skin types are 33 percent more likely to have pigmented lesions on their soles and palms and should be evaluated to ensure the lesions are benign.
Study uncovers hard-to-detect cancer mutations
12/15/2015
New research shows that current approaches to genome analysis systematically miss detecting a certain type of complex mutation in cancer patients' tumors.
Expensive, exploratory research biopsies overused in early studies of new cancer drugs
12/15/2015
For more than a decade, researchers studying the newest anticancer drugs have taken extra biopsies solely for the purpose of trying to understand the pharmacodynamics -- what the drug does to the...
Treating colon cancer with vitamin A
12/15/2015
A leading cause of cancer deaths worldwide, colon cancer is famously resistant to treatment.
Experimental drugs that change energy supply in cells could slow brain tumor growth
12/15/2015
Experimental drugs that alter cell metabolism also halted tumor growth and extended survival in mice with cancers linked to changes in the same gene, according to a new study led by researchers at...
Researchers create cellular 'ORACLs' to aid drug discovery
12/15/2015
A team of researchers at UC San Francisco has devised a new approach for early stage drug discovery that uses techniques from the world of computer vision in combination with a powerful new tool: a...
Venetoclax delivers high response rate in CLL patients
12/15/2015
New research presented at the annual meeting of the American Society of Hematology shows patients with chronic lymphocytic leukemia showed high responses to venetoclax.
A rigorous evaluation of survival rates has shown that cancer patients with localised prostate cancer - the most common form of prostate cancer - have a better chance of survival if treated by...
Prostate cancer cells succumb to 'suicide gene therapy'
12/15/2015
A phase 2 trial of a gene therapy that makes the immune system attack tumor cells in prostate cancer patients shows improvement in 5-year survival over historical controls.